The authors examine the largest 20 US commercial payers’ coverage policies and identify variation in how interventions are covered and the evidence reviewed in them. Study Design: Review of publicly ...
Patient-Centered Approach to Benefit–Risk Characterization Using Number Needed to Benefit and Number Needed to Harm: Advanced Non–Small-Cell Lung Cancer Following the Preferred Reporting Items for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results